Covered recipient · General Payments record
FRANCOISE MARVEL
Allopathic & Osteopathic Physicians Hospitalist
General Payments · PY2022–2024
$47,166.51
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $11,061.65 | 2 |
| Food and Beverage | $787.17 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $11,749.04 | 10 |
| Novo Nordisk AS | $99.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $92.58 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621584 | CMS |
| Amgen Inc. | $76.28 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111645407 | CMS |
| Amgen Inc. | $8,086.65 | 04/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1111645405 | CMS |
| Amgen Inc. | $80.35 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621586 | CMS |
| Amgen Inc. | $99.11 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621588 | CMS |
| Amgen Inc. | $47.70 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111645409 | CMS |
| Amgen Inc. | $2,975.00 | 07/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1111645411 | CMS |
| Amgen Inc. | $30.22 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621590 | CMS |
| Amgen Inc. | $136.98 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621592 | CMS |
| Amgen Inc. | $124.17 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117621594 | CMS |
| Novo Nordisk Inc | $99.78 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097406837 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.